MS risk sharing scheme. Some clarification needed.
Richards
Richard G
RG
D003362:Cost-Benefit Analysis; D006297:Health Services Accessibility / Q000191:economics*; D006801:Humans; D016899:Interferon-beta / Q000191:economics*; D009103:Multiple Sclerosis / Q000188:drug therapy*
D016899:Interferon-beta